56. Behcet disease Clinical trials / Disease details
Clinical trials : 81 / Drugs : 107 - (DrugBank : 30) / Drug target genes : 36 - Drug target pathways : 116
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00001865 (ClinicalTrials.gov) | July 1999 | 3/11/1999 | HAT in Eye Complications of Behcet's Disease | A Study to Investigate the Safety and Efficacy of HAT to Treat the Ocular Complications Related to Behcet's Disease | Behcet's Syndrome;Retinal Disease;Uveitis | Drug: Daclizumab | National Eye Institute (NEI) | NULL | Completed | N/A | N/A | Both | 26 | Phase 2 | United States |